Clinical Trial

Postprandial Regulation of Bone Perfusion in Healthy Individuals

Study acronym: GA-27
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn whether certain natural hormones - Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2, (GLP-2), and amylin - affect blood flow to the bones.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-25.
Trial Details
NCT Number NCT07679516
Lead Sponsor University of Copenhagen
Collaborators: Rigshospitalet, Denmark
Conditions Healthy Adult Participants, Bone Physiology, Bone Blood Flow Regulation, Peptide Hormones
Enrollment 15 participants
Start Date 2026-07-19
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-09